609 related articles for article (PubMed ID: 15704202)
1. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
Massie J; Clements B;
Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
[TBL] [Abstract][Full Text] [Related]
3. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
5. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
[TBL] [Abstract][Full Text] [Related]
6. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
7. Emerging issues in cystic fibrosis newborn screening.
Castellani C; Massie J
Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
[TBL] [Abstract][Full Text] [Related]
8. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
Soultan ZN; Foster MM; Newman NB; Anbar RD
J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
[TBL] [Abstract][Full Text] [Related]
9. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
Tluczek A; Koscik RL; Farrell PM; Rock MJ
Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
[TBL] [Abstract][Full Text] [Related]
12. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
[TBL] [Abstract][Full Text] [Related]
13. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
[TBL] [Abstract][Full Text] [Related]
14. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
[TBL] [Abstract][Full Text] [Related]
16. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
Keiles S; Koepke R; Parad R; Kharrazi M;
J Cyst Fibros; 2012 May; 11(3):257-60. PubMed ID: 22209734
[TBL] [Abstract][Full Text] [Related]
17. New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population.
Giusti R; Badgwell A; Iglesias AD;
Pediatrics; 2007 Feb; 119(2):e460-7. PubMed ID: 17272608
[TBL] [Abstract][Full Text] [Related]
18. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
Munck A; Roussey M
Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
[TBL] [Abstract][Full Text] [Related]
19. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011].
Mornand A; Barben J; Hafen G
Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515
[TBL] [Abstract][Full Text] [Related]
20. Screening for cystic fibrosis: the importance of using the correct tools.
Shah U; Moatter T
J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
